Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax CreditGlobe Newswire • about 2 months agoBERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...